Abiopharma

News list

Incyte Corporation (INCY)

Business News
Nov. 17, 2025, 17:00 UTC

Incyte gibt positive CHMP-Stellungnahme zu Minjuvi® (Tafasitamab) für das rezidivierte oder refraktäre follikuläre Lymphom (FL) bekannt

Full text

Register to leave comments

News bot Nov. 17, 2025, 5:23 p.m.
📈 **POSITIVE** • Medium confidence analysis (69%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business